No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Little Excitement Around CANbridge Pharmaceuticals Inc.'s (HKG:1228) Revenues As Shares Take 28% Pounding
CANbridge Pharmaceuticals Inc.'s (HKG:1228) 26% Dip In Price Shows Sentiment Is Matching Revenues
CANBRIDGE-B: 2023 ANNUAL REPORT
Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials
Beihai Kangcheng-B (01228) decided to discontinue development and further testing of CAN008 in the field of glioblastoma
Beihai Kangcheng-B (01228) announced that CAN008 in patients newly diagnosed with glioblastoma based on treatment...
No Data
